Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

Cardiovascular (CV) disease remains the leading cause of morbidity and mortality worldwide and poses an ongoing challenge with the aging population. Elevated low-density lipoprotein cholesterol (LDL-C) is an established risk factor for atherosclerotic cardiovascular disease (ASCVD), and the expert c...

Descripción completa

Detalles Bibliográficos
Autores principales: Duprez, Daniel A, Handelsman, Yehuda, Koren, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548340/
https://www.ncbi.nlm.nih.gov/pubmed/33116551
http://dx.doi.org/10.2147/VHRM.S261719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548340/
https://www.ncbi.nlm.nih.gov/pubmed/33116551
http://dx.doi.org/10.2147/VHRM.S261719

Ejemplares similares